Targeting human dendritic cells in situ to improve vaccines.
about
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and ImmunotherapyPros and Cons of Antigen-Presenting Cell Targeted Tumor VaccinesImmunomodulatory Effects of Nanoparticles on Skin Allergy.Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.pH-Dependent recognition of apoptotic and necrotic cells by the human dendritic cell receptor DEC205.Surface display of an anti-DEC-205 single chain Fv fragment in Lactobacillus plantarum increases internalization and plasmid transfer to dendritic cells in vitro and in vivoEnhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.Keratin mediates the recognition of apoptotic and necrotic cells through dendritic cell receptor DEC205/CD205.Brain Tumor Immunotherapy: What have We Learned so Far?New approaches from nanomedicine for treating leishmaniasis.Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies.Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy.Nanomedicine approaches to improve cancer immunotherapy.An overview on the role of silica-based materials in vaccine development.In vivo targeting of protein antigens to dendritic cells using anti-DEC-205 single chain antibody improves HIV Gag specific CD4(+) T cell responses protecting from airway challenge with recombinant vaccinia-gag virus.Targeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.Regulation of dendritic cell function by insulin/IGF-1/PI3K/Akt signaling through klotho expression.High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization.Exploration of graphene oxide as an intelligent platform for cancer vaccines.Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis.Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment.Dendritic cells loaded with the lysate of tumor cells infected with Newcastle Disease Virus trigger potent anti-tumor immunity by promoting the secretion of IFN-γ and IL-2 from T cellsIntestinal CD103CD11b cDC2 Conventional Dendritic Cells Are Required for Primary CD4 T and B Cell Responses to Soluble Flagellin
P2860
Q26782566-9E6C1DD1-D52F-4D2F-82AB-C75DB842A9EDQ27013679-6F916630-3410-42F6-95F6-62729A9B8706Q33822345-99892159-48EC-42F1-87D6-FFE28B2CC0D6Q33867299-2236BF96-7EA2-47F8-BD2D-673CA4C563AEQ35740277-53DEEE44-C87F-421D-BF5A-2903E9220BE8Q35816760-73C1ADE8-CEB1-40DF-BDAF-E122E47BA28DQ37367163-1FAD0012-F8BB-4BEA-BA95-CCD978C3CFAFQ37451033-C702EF50-9E0A-4648-BA20-081A6D86F5C4Q38542113-50ED1693-4E40-45E2-AFC7-BDE9ED5551E1Q38612712-90F4C1CD-5EA6-49AC-A4C9-B15975CB2A72Q38658279-F21FAF2C-4842-44C2-BB13-9CD202A716B5Q38961842-145308FD-F6E5-49D5-AE79-65D5F5408AD0Q39179977-0752A054-4435-4653-AB93-9C74DE48D7F5Q39781727-50BF3894-FA52-4300-8617-FFE4FCBFB20FQ40214060-175F99A2-67D6-4864-9229-A797DF2446A8Q40452198-F1F0482E-FCE0-46CD-9E7E-D009A2A0E93BQ46465278-0D2D154B-C01B-424E-B087-EC0ABB1D0811Q47314216-28F71094-61B4-482F-8845-9FADAD22F066Q51702751-06655F1A-607F-4E82-919E-D8830FF4C49AQ51743228-490ADB53-080E-4D87-AD1D-7738F0DD3447Q52579251-2353142A-542E-48C2-885D-335269E5B0D4Q57178786-3B20DDFA-0BC6-4A7D-82EE-0D26F0CED535Q58606326-8060BE7C-9CB1-4975-9152-AA8EF9B25B05
P2860
Targeting human dendritic cells in situ to improve vaccines.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Targeting human dendritic cells in situ to improve vaccines.
@en
type
label
Targeting human dendritic cells in situ to improve vaccines.
@en
prefLabel
Targeting human dendritic cells in situ to improve vaccines.
@en
P2860
P1433
P1476
Targeting human dendritic cells in situ to improve vaccines
@en
P2093
Kavita M Dhodapkar
Madhav V Dhodapkar
P2860
P356
10.1016/J.IMLET.2014.07.004
P433
P577
2014-07-27T00:00:00Z